STORY SUMMARY

The FDA wants to pull its approval of a drug. It’s not so easy.

The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?

This is a brief summary of reporting from Ars Technica Science. Read the original for the full article and context.

Read original reporting ↗

More from Ars Technica Science · Latest headlines